@FiercePharma: TNF inhibitors-Enbrel, Remicade, Humira, etc.--may actually lower heart attack risks in psoriasis patients. More | Follow @FiercePharma
> India's Agila Specialties, a unit of Strides Arcolab said to be on the block, paid its CEO enough last year to put him among the highest-paid executives in India. Report
> Johnson & Johnson ($JNJ) agreed to pay about $600,000 to settle three cases over hip implants recalled in 2010, the first among thousands of patient lawsuits it faces. Report
> Pfizer ($PFE) has to sort out a host of manufacturing questions as it prepares to spin off the animal health unit Zoetis, including which Pfizer sites will continue to turn out the unit's products. Report
> Johnson & Johnson CEO William Weldon will serve on the JPMorgan Chase committee investigating the derivative trades that spawned $5.8 billion in losses this year. Report
> Researchers advised the WHO to review a drug used to prevent life-threatening bleeding in childbirth, saying there's not enough evidence that it's effective. Report
> Watson Pharmaceuticals ($WPI) launched a knockoff version of Sunovion Pharmaceuticals' bronchospasm remedy Xopenex. Report
@FierceMedDev: More trouble for St. Jude as study questions safety of Durata leads. Report | Follow @FierceMedDev
@MarkHFierce: GE is among three investors who committed $20 million to Ornim, a maker of a non invasive blood flow/oxygen monitor. Release | Follow @MarkHFierce
@DamianFierce: Maine's medical device middlemen fret over how impending 2.3% tax will cut into profits. More | Follow @DamianFierce
> General Electric invests in Israeli maker of blood monitoring device. News
> Medtronic posts 5% income boost despite CRM dip in Q1. More
> Discontinued St. Jude catheter finds new life at Vascular Solutions. Item
Biotech News
@FierceBiotech: MediciNova snags $20M deal to finance R&D work. Item | Follow @FierceBiotech
@JohnCFierce: Kineta uses unorthodox strategy to push autoimmune drug into clinic--my take on an unusual approach to drug development. Editor's Corner | Follow @JohnCFierce
@RyanMFierce: Closer to mainstream media, Fast Company mag caught up with Sanofi's social strategy for diabetes. More | Follow @RyanMFierce
> Controversial stem cell treatment put to test in groundbreaking autism study. Article
> Buzz: Genomics startup Halcyon Molecular tanks. More
> FDA pushes back PDUFA date on crucial Pfizer app for tofacitinib. Story
> Allergan adds $1.5B R&D pact as it builds ophthalmology pipeline. News
Pharma Manufacturing News
> Roche CEO says Genentech has resolved Perjeta production problems. Story
> $19M Cambrex plant expansion to benefit manufacturer and local community. News
> GSK closes 50-year-old India plant, 'retires' 330. Report
> API growth to spurt in Central, South America. More
Biotech Research News
> Old antifungal drug also fights tumors, researchers discover. Article
> Scientists discover wound-healing secret. Story
> A cool $1M to fund preclinical work on nanotech/siRNA cancer drug. More
> Dana-Farber, Broad Institute spot CYCLOPS gene class in cancer fight. New
And Finally... Newer psoriasis drugs may lower heart attack risks for patients. Report